Overview

Eylea Post Marketing Surveillance(PMS)

Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The objective of this PMS is to gain information about safety and efficacy in real practice as a regulatory commitment required by MFDS
Details
Lead Sponsor:
Bayer
Collaborator:
Regeneron Pharmaceuticals
Treatments:
Aflibercept